Potential adverse effects of negative publicity surrounding antivirals for influenzaBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3015 (Published 30 April 2014) Cite this as: BMJ 2014;348:g3015
- Jake Dunning, honorary research fellow1
- 1Centre for Respiratory Infection, Imperial College London, London W2 1PG, UK
Influenza is not trivial. During the first post-pandemic winter (2010-11), there were 8797 hospital admissions for influenza in England alone. At the peak, there were 851 influenza cases in critical care beds (~20% of UK capacity), mostly younger adults and children with pandemic H1N1.1 Prehospital antiviral use was uncommon (<3%), yet antibacterial drugs were often prescribed (25% in our series; unpublished data).
The latest Cochrane review of neuraminidase inhibitors for influenza was impressive but did not investigate antiviral effectiveness in severe influenza, illness caused by pandemic …
Log in using your username and password
Log in through your institution
Sign up for a free trial